Pathophysiology of cardiovascular disease and renal failure

Cardiology Clinics

Volumn 23, Issue 3, 2005, Pages 311-317

  Dikow, Ralf ^a   Zeier, Martin ^a   Ritz, Eberhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY; HEART; HEART ARREST; HUMAN; KIDNEY FAILURE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; TARGET ORGAN;

AORTA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY VESSELS; HEART; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 23244435998     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.03.002     Document Type: Review

References (67)

1. A. Lindner, B. Charra, and D.J. Sherrard Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 1974 697 701
2. P.S. Parfrey, and R.N. Foley The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 1999 1606 1615
3. L.M. Ruilope, D.J. van Veldhuisen, and E. Ritz Renal function: the Cinderella of cardiovascular risk profile J Am Coll Cardiol 38 2001 1782 1787
4. E. Ritz, and W.M. McClellan Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences J Am Soc Nephrol 15 2004 513 516
5. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 2003 1050 1065
6. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169
7. A.E. Raine, R. Margreiter, and F.P. Brunner Report on management of renal failure in Europe, XXII, 1991 Nephrol Dial Transplant 7 Suppl 2 1992 7 35
8. US Renal Data Systems. National Institutes of Health: annual data report. 1999.
9. H.L. Hillege, V. Fidler, and G.F. Diercks Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777 1782
10. K. Borch-Johnsen, B. Feldt-Rasmussen, and S. Strandgaard Urinary albumin excretion. An independent predictor of ischemic heart disease Arterioscler Thromb Vasc Biol 19 1999 1992 1997
11. J.C. Verhave, H.L. Hillege, and J.G. Burgerhof Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women J Am Soc Nephrol 14 2003 1330 1335
12. L. Mykkanen, D.J. Zaccaro, and L.E. Wagenknecht Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study Diabetes 47 1998 793 800
13. A.C. Pereira, A.B. Pereira, and G.F. Mota NPHS2 R229Q functional variant is associated with microalbuminuria in the general population Kidney Int 65 2004 1026 1030
14. N.B. Shulman, C.E. Ford, and W.D. Hall Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group Hypertension 13 1989 I80 I93
15. R.M. Henry, P.J. Kostense, and G. Bos Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study Kidney Int 62 2002 1402 1407
16. L.M. Ruilope, A. Salvetti, and K. Jamerson Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study J Am Soc Nephrol 12 2001 218 225
17. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
18. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
19. M.G. Shlipak, L.F. Fried, and C. Crump Cardiovascular disease risk status in elderly persons with renal insufficiency Kidney Int 62 2002 997 1004
20. R.S. Wright, G.S. Reeder, and C.A. Herzog Acute myocardial infarction and renal dysfunction: a high-risk combination Ann Intern Med 137 2002 563 570
21. Y. Liu, J. Coresh, and J.A. Eustace Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition JAMA 291 2004 451 459
22. F. Kronenberg, U. Neyer, and K. Lhotta The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up J Am Soc Nephrol 10 1999 1027 1036
23. T. Shoji, Y. Nishizawa, and T. Kawagishi Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients J Am Soc Nephrol 9 1998 1277 1284
24. G.A. Block, T.E. Hulbert-Shearon, and N.W. Levin Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 1998 607 617
25. S.K. Ganesh, A.G. Stack, and N.W. Levin Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2131 2138
26. L.A. Stevens, O. Djurdjev, and S. Cardew Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes J Am Soc Nephrol 15 2004 770 779
27. M.G. Shlipak, L.F. Fried, and C. Crump Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation 107 2003 87 92
28. P. Stenvinkel, O. Heimburger, and B. Lindholm Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome) Nephrol Dial Transplant 15 2000 953 960
29. C. Zoccali, F. Mallamaci, and G. Tripepi Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 13 2002 134 141
30. J.T. Kielstein, R.H. Boger, and S.M. Bode-Boger Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease J Am Soc Nephrol 10 1999 594 600
31. M. Ketteler, P. Bongartz, and R. Westenfeld Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study Lancet 361 2003 827 833
32. G. Zuanetti, A.P. Maggioni, and W. Keane Nephrologists neglect administration of betablockers to dialysed diabetic patients Nephrol Dial Transplant 12 1997 2497 2500
33. C. Zoccali, F. Mallamaci, and S. Parlongo Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease Circulation 105 2002 1354 1359
34. J.Z. Ma, J. Ebben, and H. Xia Hematocrit level and associated mortality in hemodialysis patients J Am Soc Nephrol 10 1999 610 619
35. A. Levin, C.R. Thompson, and J. Ethier Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134
36. F.H. Bahlmann, K. De Groot, and J.M. Spandau Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
37. M. Koc, A. Bihorac, and M.S. Segal Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients Am J Kidney Dis 42 2003 704 712
38. F.H. Bahlmann, K. DeGroot, and T. Duckert Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Kidney Int 64 2003 1648 1652
39. S.G. Rostand, J.C. Gretes, and K.A. Kirk Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis Kidney Int 16 1979 600 611
40. S.G. Rostand, K.A. Kirk, and E.A. Rutsky Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease Kidney Int 22 1982 304 308
41. E. Tvedegaard, and O. Kamstrup The effect of chronic renal failure in rabbits on plasma lipids and the concentration of cholesterol, calcium and phosphate in the aortic wall Proc Eur Dial Transplant Assoc 17 1980 240 246
42. M. Buzello, J. Tornig, and J. Faulhaber The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia J Am Soc Nephrol 14 2003 311 316
43. S. Bro, F. Moeller, and C.B. Andersen Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-e-deficient mice J Am Soc Nephrol 15 2004 1495 1503
44. K. Amann, B. Wolf, and C. Nichols Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 29 1997 770 775
45. K. Amann, and E. Ritz Cardiovascular abnormalities in ageing and in uraemia - only analogy or shared pathomechanisms? Nephrol Dial Transplant 13 Suppl 7 1998 6 11
46. G.M. London, B. Pannier, and M. Agharazii Forearm reactive hyperemia and mortality in end-stage renal disease Kidney Int 65 2004 700 704
47. M.E. Safar, G.M. London, and G.E. Plante Arterial stiffness and kidney function Hypertension 43 2004 163 168
48. G.M. London Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function J Am Soc Nephrol 14 2003 S305 S309
49. J. Blacher, M.E. Safar, and A.P. Guerin Aortic pulse wave velocity index and mortality in end-stage renal disease Kidney Int 63 2003 1852 1860
50. M.E. Safar, J. Blacher, and B. Pannier Central pulse pressure and mortality in end-stage renal disease Hypertension 39 2002 735 738
51. U. Schwarz, M. Buzello, and E. Ritz Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure Nephrol Dial Transplant 15 2000 218 223
52. C. Schafer, A. Heiss, and A. Schwarz The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J Clin Invest 112 2003 357 366
53. S.M. Moe, D. Duan, and B.P. Doehle Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels Kidney Int 63 2003 1003 1011
54. N.X. Chen, K.D. O'Neill, and D. Duan Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells Kidney Int 62 2002 1724 1731
55. J. Blacher, A.P. Guerin, and B. Pannier Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 2001 938 942
56. M. Matsuoka, K. Iseki, and M. Tamashiro Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis Clin Exp Nephrol 8 2004 54 58
57. R. Dikow, L.P. Kihm, and M. Zeier Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol 15 2004 1530 1536
58. G. Mall, M. Rambausek, and A. Neumeister Myocardial interstitial fibrosis in experimental uremia-implications for cardiac compliance Kidney Int 33 1988 804 811
59. K. Amann, and E. Ritz Microvascular disease - the Cinderella of uraemic heart disease Nephrol Dial Transplant 15 2000 1493 1503
60. P.S. Parfrey, R.N. Foley, and J.D. Harnett Outcome and risk factors for left ventricular disorders in chronic uraemia Nephrol Dial Transplant 11 1996 1277 1285
61. K. Amann, K. Tyralla, and M.L. Gross Cardiomyocyte loss in experimental renal failure: prevention by ramipril Kidney Int 63 2003 1708 1713
62. R.L. Converse Jr., T.N. Jacobsen, and R.D. Toto Sympathetic overactivity in patients with chronic renal failure N Engl J Med 327 1992 1912 1918
63. I.H. Klein, G. Ligtenberg, and P.L. Oey Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension J Am Soc Nephrol 12 2001 2427 2433
64. G. Cice, L. Ferrara, and A. D'Andrea Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial J Am Coll Cardiol 41 2003 1438 1444
65. K. Malmberg, A. Norhammar, and L. Ryden Insulin treatment post myocardial infarction: the DIGAMI study Adv Exp Med Biol 498 2001 279 284
66. E. Ritz, and M. Koch Morbidity and Mortality due to hypertension in patients with renal failure Am J Kidney Dis 21 1993 113 118
67. A.E. Raine, A.M. Seymour, and A.F. Roberts Impairment of cardiac function and energetics in experimental renal failure J Clin Invest 92 1993 2934 2940